A5045354813- Pancreatic and Hepatic Oncology Research
- Genetic factors in colorectal cancer
- Colorectal Cancer Screening and Detection
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Bleeding Diagnosis and Treatment
- Pancreatitis Pathology and Treatment
- Esophageal and GI Pathology
Instituto Nacional de Enfermedades Neoplásicas
2021-2024
The standard treatment for ampullary adenocarcinoma is pancreaticoduodenectomy. Identification of preoperative risk factors might help the clinician to select patients fit resection and potentially decrease morbidity mortality after PD. We conducted a cohort study determine related 90-day severe PD.We retrospective in with diagnosis who underwent an open PD between January 2010 December 2019 at our tertiary centre.Independent predictors were albumin-bilirubin (ALBI) grade 3 (OR: 21.7; CI 95:...
Ampullary adenocarcinoma (AAC) is a rare neoplasm that accounts for only 0.2% of all gastrointestinal cancers. Its incidence rate lower than 6 cases per million people. Different prognostic factors have been described AAC and are associated with wide range survival rates. However, these studies exclusively conducted in patients originating from Asian, European, North American countries.To evaluate the histopathologic predictors overall (OS) South treated curative pancreaticoduodenectomy...
Extended distal pancreatectomy often requires resection of vascular structures and adjacent organs, potentially leading to gastric venous congestion. This case report describes a 49-year-old female who underwent radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma. During the procedure, segmental congestion was observed resolved by anastomosing left vein adrenal vein. The in-hospital postoperative recovery initially uneventful; however, patient readmitted...